Anti-A1Leb: a mind boggler by Gupta, A. et al.
IMMUNOHEMATOLOGY, Volume 37, Number 2, 2021 69
The Lewis blood group system is unique because antigens are 
neither alleles of the same gene nor are they synthesized by 
red blood cells (RBCs); rather, they are adsorbed onto the RBC 
membrane from plasma as glycolipids. Antibodies against Lewis 
antigens are predominantly naturally occurring immunoglobulin 
(Ig)M type that sometimes react at 37°C and the antihuman 
globulin phase. Lewis compound antigens, ALeb and BLeb, have 
been described that were confirmed because of the presence 
of antibodies against them. These compound antigens are the 
result of an interaction between ABO, H, SE, and LE genes. 
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The Lewis blood group system (Le) is unique because it 
is the only system in which the antigens are not synthesized 
by red blood cells (RBCs); rather, the antigens are passively 
adsorbed onto the RBC membrane.1 Le antigens are soluble 
carbohydrate moieties formed by tissue cells and secreted 
by body secretions like saliva, where they appear as 
glycoproteins; in plasma, however, they appear as glycolipids. 
The Le phenotype depends on ABH secretor status of an 
individual, although FUT2 and FUT3, the secretor (SE) gene 
and LE gene on locus 19q and 19p, respectively, are inherited 
independently.2 Genetic interaction also exists between the LE 
and ABO genes because the amount of Le antigen detectable 
on the RBC is influenced by the ABO genes inherited, and the 
products of ABO and LE share the same precursor substrate. 
Individuals who are Le(a+b–) are nonsecretors, Le(a–b+) are 
secretors, and Le(a–b–) can be secretors or nonsecretors. 
Although individuals who are Le(a+b–) are nonsecretors, 
Lea substance is still secreted regardless of secretor status. 
An individual can be a nonsecretor (sese) of ABH and still 
secrete Lea into body fluids, producing the phenotype Le(a+) 
on the RBCs. Frequency of the Le phenotypes in the Indian 
population are as follows: Le(a+b–) 20.82 percent, Le(a–b+) 
60.57 percent, and Le(a–b–) 18.61 percent.3 Compound 
antigens in the Lewis blood group system include ALeb and 
BLeb, which are the result of interaction between ABO, H, SE, 
and LE genes.4 Antibody against these compound antigens 
(e.g., anti-ALeb) has been shown to react only when RBCs 
possess both A and Leb together.1
Here, we describe the immunohematology workup of a 
rare and interesting case of incompatible crossmatches with 
negative indirect antiglobulin test and the antibody identified 
as anti-A1Leb.
Case Report
A 61-year-old male patient was admitted to a local 
hospital with complaints of hematemesis, abdominal 
distension, decreased appetite, weight loss, weakness, and 
itchy and yellow discoloration of the skin. He was a known 
chronic alcoholic and was diagnosed with hepatitis C in 2010. 
Baseline investigations at the time of admission revealed low 
hemoglobin (Hgb) of 5 g/dL (normal range 13.5–17.5 g/dL 
for men), deranged liver function tests with markedly raised 
bilirubin and enzymes, abnormal coagulation profile with 
raised international normalized ratio, low total protein, low 
serum albumin, and negative α-fetoprotein. Because of the 
low Hgb (5 g/dL), a request was sent for packed red blood 
cell (PRBC) transfusion. The hospital blood bank performed 
routine antibody screening and reported a positive result with 
incompatible PRBC crossmatch. Because of limited resources, 
the patient’s samples were referred to the Department of 
Transfusion Medicine in our hospital for further antibody 
identification workup, and 2 units of antigen-negative 
antihuman globulin (AHG) crossmatch-compatible PRBCs 
were requested. Before his referral, the patient had been 
transfused with 1 unit of PRBCs 3 years prior and with 1 unit 
2 weeks prior.
The patient’s RBCs were typed as group A, D+ with a 
positive autocontrol (2+; AHG phase). Direct antiglobulin tests 
(DATs) with polyspecific and monospecific AHG reagents 
were positive (poly = 2+; immunoglobulin [Ig]G = 2+; C3d = 
2+). Indirect antiglobulin test (IAT) with a three-cell screening 
panel was negative. Two randomly selected PRBC units 
crossmatched by column-agglutination technology (CAT) 
were found to be incompatible (2+). A repeat crossmatch was 
performed using a fresh sample with group A, D+; group O, 
D+; and group A2, D+ PRBC donor units. Tables 1–6 briefly 
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summarize the immunohematology workup performed. 
(Reagent RBC panel, antisera for phenotyping, CAT gel cards, 
DAT cards, DTT, enzymes, and 22% bovine albumin were 
from Bio-Rad, Hercules, CA; Anti-A1 from J. Mitra, New 
Delhi, India.) After detailed workup, a suspicion of a compound 
antibody directed against antigens in two blood group systems 
(i.e., ABO and Lewis blood group systems) was raised. The 
offending antibody was identified as anti-A1Leb, and 2 units 
of group A1, Le(b–) AHG crossmatch-compatible PRBCs were 
found and issued to the patient (Table 6). No adverse events 
were reported during or after transfusion.
Discussion
Le antigens are not alleles of the same gene. Their synthe-
sis depends on the interaction of the enzymes (transferases) 
produced by the LE and SE genes. The Lewis and secretor 
transferases fucosylate (add fucose) Type 1 chains, which 
are predominant types in secretions and plasma and refer to 
the beta linkage of the first carbon of galactose to the third 
carbon of N-acetylglucosamine (13 linkage) residue of 
the precursor structure.4 The SE gene codes for the enzyme 
(α1,2-L-fucosyltransferase), which adds terminal fucose to 
the Type 1 chain to form Type 1H. The Le allele codes for 
α1,4-L-fucosyltransferase, which transfers L-fucose to the 
Type 1H chain on glycoprotein or glycolipid structures to 
form Leb. Small amounts of Lea are made before the secretor 
enzyme can add the terminal fucose. If these individuals also 
have A or B genes, Type 1H structures will be converted to A or 
B structures and the Le fucosyltransferase will then produce 
ALeb or BLeb.1,2
Le(a–b–) phenotype is not the result of the absence of 
Lewis antigens on the RBCs caused by the absence of the 
Lewis gene (FUT3), but rather by explicit point mutations 
in the FUT3 and other genes.5,6 Although serologically 
Table 1. Basic immunohematologic workup 
Testing Result
Blood group/D type A1, D+
DAT IgG: 2+, C3d: 2+
IAT Negative
Autocontrol (AHG)* 2+
Anti-A1 lectin Positive (4+)
DAT eluate† against A, D+ RBCs 3+
DAT eluate† against O, D+ RBCs Negative
DAT eluate† against O, D– RBCs Negative
*Cell separation using microhematocrit tubes.
†Heat elution.
DAT = direct antiglobulin test; Ig = immunoglobulin; IAT = indirect 
antiglobulin test; AHG = antihuman globulin; RBCs = red blood cells.
Table 6. Crossmatch with phenotype-matched PRBC units 
ABO group Lewis type CAT crossmatch CTT crossmatch
A1 Le(a–b–) Compatible Compatible
A1 Le(a–b+) Incompatible (2+) Incompatible (1+)
A2 Le(a–b+) Compatible Compatible
O Le(a–b+) Compatible Compatible
PRBC = packed red blood cell; CAT = column-agglutination technology;  
CTT = conventional tube test.
Table 2. Crossmatch performed with random PRBC units








A1, D+ 6 2+ 1+ 1+
O, D+ 6 Compatible Compatible Compatible
A2, D+ 2 Compatible Compatible Compatible
PRBC = packed red blood cell; CAT = column-agglutination technology;  
RT = room temperature.
Table 3. Extended phenotype (testing on pre-transfusion sample)
D C E c e K Jka Jkb Fya Fyb M N S s Lea Leb Control*
+ + Neg Neg + Neg + Neg + + + Neg Neg + Neg Neg Neg 
*22% bovine albumin. Neg = negative.
Table 4. Inhibition studies performed using saliva
Patient serum antibody Saliva
Reactivity with A1,  
Le(a–b+) RBCs
Anti-A1Leb None Present
Anti-A1Leb A1, Le(a+b–) Present
Anti-A1Leb O, Le(a–b+) Present
Anti-A1Leb A1, Le(a–b+) Inhibited
Anti-A1Leb A2, Le(a–b+) Present
RBCs = red blood cells.
Table 5. Testing with 0.1 M DTT-treated serum
Reciprocal dilution
Test sample 2 4 8 16 32 Interpretation
Serum + DTT 2+ 1+ 0 0 0
IgM + IgG
Serum + PBS 2+ 1+ 1+ 0 0
DTT = dithiothreitol; PBS = phosphate-buffered saline; Ig = immunoglobulin.
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Compound Lewis antibody
Lewis antigens are absent on the RBCs, Lewis and ABO 
substances can be detected in the tissues and secretions of 
the Le(a–b–) secretors, depending on the secretory status and 
ABO genotype of the person. The reported prevalence of the 
Le(a–b–) phenotype in the Indian population is 18 percent.3
Our patient had a compound antibody, anti-A1Leb, 
reacting only with RBCs possessing both A1 and Leb antigens 
(i.e., against compound antigen A1Leb). Anti-A1Leb was first 
identified by Seaman et al.7 in 1968 in a patient with blood 
group A1B and the Le(a–b–) phenotype. They reported that 
the antibody reacts with A1 Le(b+) RBCs but not with RBCs 
having A1 or Leb alone.7 This antibody of compound speci-
ficity was called “Siedler.” A literature search on antibodies 
that react with RBCs containing antigens against two separate 
blood group systems includes “Magard,” which reacts against 
RBCs with secretor phenotype A1 Le(a–b–).7 Tilley et al.8 in 
1975 reported that A, B, and ALeb substances detected in the 
lipid fractions are glycosphingolipids that react with anti-A, 
anti-B, or anti-ALeb, respectively. 
Our patient’s sample tested as group A1, D+ with 
incompatible crossmatch and negative IAT. Heat elution 
of DAT+ RBCs reveals an eluate that was reactive with A1 
RBCs (2+; AHG) but was nonreactive against group O RBCs 
(Table 1). Multiple blood units were crossmatched using CAT 
and conventional tube testing (Table 2); among them, all group 
A1, D+ RBC units were found to be incompatible, whereas all 
group O, D+ and A2, D+ blood units were compatible with 
patient’s serum. Ruling out all donor- and patient-related 
causes of incompatible crossmatch (both at room temperature 
and 37°C) with a negative IAT, the diagnosis was narrowed 
down to a compound antibody reacting against two different 
antigens. Such a compound antibody was identified as anti-
A1Leb, which reacts only in the presence of both A1 and Leb 
antigens (Table 6).
Lewis antibodies are generally naturally occurring IgM 
antibodies that sometimes react at 37°C and AHG phase, 
although weakly, and are enhanced by enzyme treatment. Our 
patient has mixed IgM + IgG antibody (Table 5), which was 
clinically significant. Patient Lewis phenotype, performed by 
cell separation using microhematocrit tubes, was Le(a–b–), as 
seen in Table 3; a person with this phenotype could produce 
anti-Leb. Table 4 shows that reactivity of anti-A1Leb with 
group A1, Le(a–b+) RBCs can be inhibited with group A1, 
Le(a–b+) saliva but not with group O Le(a–b+), A2 Le(a–b+), 
A1 Le(a–b–), or A1 Le(a+b–) saliva. One group A1, Le(a+b–) 
PRBC unit was typed, crossmatched, and transfused to the 
patient; the post-transfusion period was uneventful.
We find this case interesting, since the immunohematol-
ogy workup created confusion about the type and nature of 
the antibody. This case report also highlights the importance 
of using the traditional crossmatch at the AHG phase because 
reactivity could be missed with the electronic crossmatch or 
type-and-screen protocol.
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